115 related articles for article (PubMed ID: 29107690)
1. Effects of oral and subcutaneous administration of HSP60 on myeloid-derived suppressor cells and atherosclerosis in ApoE-/- mice.
Hu Y; Chen Z; Jiang L; Chen F; Jin R; Cheng L
Biochem Biophys Res Commun; 2018 Apr; 498(4):701-706. PubMed ID: 29107690
[TBL] [Abstract][Full Text] [Related]
2. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis.
Thota LN; Ponnusamy T; Lu X; Mundkur L
Cardiovasc Drugs Ther; 2019 Aug; 33(4):385-398. PubMed ID: 31332656
[TBL] [Abstract][Full Text] [Related]
4. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.
Mundkur L; Mukhopadhyay R; Samson S; Varma M; Kale D; Chen D; Shivaprasad S; Sivanandan H; Soman V; Lu X; Kakkar VV
PLoS One; 2013; 8(3):e58364. PubMed ID: 23505495
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides.
Grundtman C; Jakic B; Buszko M; Onestingel E; Almanzar G; Demetz E; Dietrich H; Cappellano G; Wick G
Atherosclerosis; 2015 Sep; 242(1):303-10. PubMed ID: 26233917
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
[TBL] [Abstract][Full Text] [Related]
7. Oral Tolerization with Mycobacterial Heat Shock Protein 65 Reduces Chronic Experimental Atherosclerosis in Aged Mice.
Wick C; Onestingel E; Demetz E; Dietrich H; Wick G
Gerontology; 2018; 64(1):36-48. PubMed ID: 28910785
[TBL] [Abstract][Full Text] [Related]
8. Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-β-dependent regulatory T cells.
Li H; Ding Y; Yi G; Zeng Q; Yang W
J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):24-30. PubMed ID: 22282240
[TBL] [Abstract][Full Text] [Related]
9. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression.
Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E
Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015
[TBL] [Abstract][Full Text] [Related]
10. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.
Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J
Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908
[TBL] [Abstract][Full Text] [Related]
11. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
12. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
13. Sublingual vaccine with GroEL attenuates atherosclerosis.
Hagiwara M; Kurita-Ochiai T; Kobayashi R; Hashizume-Takizawa T; Yamazaki K; Yamamoto M
J Dent Res; 2014 Apr; 93(4):382-7. PubMed ID: 24554540
[TBL] [Abstract][Full Text] [Related]
14. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
[TBL] [Abstract][Full Text] [Related]
15. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of
De Cicco P; Sanders T; Cirino G; Maloy KJ; Ianaro A
Front Immunol; 2018; 9():499. PubMed ID: 29636751
[TBL] [Abstract][Full Text] [Related]
17. Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice.
Mundkur L; Ponnusamy T; Philip S; Rao LN; Biradar S; Deshpande V; Kumar R; Lu X; Kakkar VV
Int J Cardiol; 2014 Aug; 175(2):340-51. PubMed ID: 24962340
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
19. Porphyromonas gingivalis HSP60 peptides have distinct roles in the development of atherosclerosis.
Jeong E; Kim K; Kim JH; Cha GS; Kim SJ; Kang HS; Choi J
Mol Immunol; 2015 Feb; 63(2):489-96. PubMed ID: 25457882
[TBL] [Abstract][Full Text] [Related]
20. A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis.
Tissot AC; Spohn G; Jennings GT; Shamshiev A; Kurrer MO; Windak R; Meier M; Viesti M; Hersberger M; Kündig TM; Ricci R; Bachmann MF
Eur J Immunol; 2013 Mar; 43(3):716-22. PubMed ID: 23254454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
